A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]
Clinical trial NCT01280721 · COMPLETED
Trial details
- NCT number
- NCT01280721
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2014-08-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.